[go: up one dir, main page]

DE602007004348D1 - Arzneimittel zur behandlung von sarkoglykanopathien - Google Patents

Arzneimittel zur behandlung von sarkoglykanopathien

Info

Publication number
DE602007004348D1
DE602007004348D1 DE602007004348T DE602007004348T DE602007004348D1 DE 602007004348 D1 DE602007004348 D1 DE 602007004348D1 DE 602007004348 T DE602007004348 T DE 602007004348T DE 602007004348 T DE602007004348 T DE 602007004348T DE 602007004348 D1 DE602007004348 D1 DE 602007004348D1
Authority
DE
Germany
Prior art keywords
sarcoglykanopathia
medicament
treatment
inhibitors
sarcoglycanopathies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007004348T
Other languages
English (en)
Inventor
Isabelle Richard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Genethon
Original Assignee
Centre National de la Recherche Scientifique CNRS
Genethon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Genethon filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE602007004348D1 publication Critical patent/DE602007004348D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE602007004348T 2006-07-18 2007-07-16 Arzneimittel zur behandlung von sarkoglykanopathien Active DE602007004348D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0653020A FR2903905B1 (fr) 2006-07-18 2006-07-18 Medicaments pour le traitement des sarcoglycanopathies
PCT/FR2007/001211 WO2008009802A2 (fr) 2006-07-18 2007-07-16 Medicaments comprenant un inhibiteur des alpha-mannosidases de classe i pour le traitement des sarcoglycanopathies

Publications (1)

Publication Number Publication Date
DE602007004348D1 true DE602007004348D1 (de) 2010-03-04

Family

ID=37663139

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007004348T Active DE602007004348D1 (de) 2006-07-18 2007-07-16 Arzneimittel zur behandlung von sarkoglykanopathien

Country Status (10)

Country Link
US (2) US8273763B2 (de)
EP (1) EP2063877B1 (de)
JP (1) JP5296678B2 (de)
AT (1) ATE454889T1 (de)
CA (1) CA2658400C (de)
DE (1) DE602007004348D1 (de)
ES (1) ES2335623T3 (de)
FR (1) FR2903905B1 (de)
PT (1) PT2063877E (de)
WO (1) WO2008009802A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2993461B1 (fr) * 2012-07-19 2014-08-08 Genethon Utilisation de composes modifiant l'epigenome pour le traitement des maladies genetiques musculaires liees a une anomalie de conformation proteique
ITMI20122065A1 (it) * 2012-12-03 2014-06-04 Univ Padova Uso dei correttori del cftr nel trattamento delle patologie del muscolo striato
CN112203654A (zh) * 2018-01-11 2021-01-08 国家健康与医学研究院 肌聚糖病的联合治疗
EP3685846A1 (de) 2019-01-24 2020-07-29 Genethon Verwendung von thiostrepton oder dessen derivaten zur behandlung von genetischen erkrankungen im zusammenhang mit einer proteinfehlfaltungserkrankung
WO2021130382A1 (en) 2019-12-26 2021-07-01 Centre D'etude Des Cellules Souches (Cecs) Combination of a proteasome inhibitor and a hdac inhibitor and its use for the treatment of genetic diseases linked to a protein conformational disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012968A1 (fr) * 1991-01-28 1992-08-06 Nippon Shinyaku Co., Ltd. Composition pharmaceutique contre les thrombis
EP1618881A1 (de) * 2004-07-20 2006-01-25 Santhera Pharmaceuticals (Schweiz) GmbH Verwendung von steroiden ohne glucocorticoid aktivität zur behandlung von muskulärer dystrophie
CA2578006A1 (en) * 2004-08-25 2006-03-02 Santhera Pharmaceuticals (Schweiz) Ag Alpha-keto carbonyl calpain inhibitors
AU2005276631A1 (en) * 2004-08-25 2006-03-02 Santhera Pharmaceuticals (Schweiz) Ag Alpha-keto carbonyl calpain inhibitors

Also Published As

Publication number Publication date
PT2063877E (pt) 2010-02-09
EP2063877A2 (de) 2009-06-03
WO2008009802A3 (fr) 2008-05-29
US20100010036A1 (en) 2010-01-14
EP2063877B1 (de) 2010-01-13
FR2903905A1 (fr) 2008-01-25
US20130035353A1 (en) 2013-02-07
US8273763B2 (en) 2012-09-25
WO2008009802A2 (fr) 2008-01-24
US8673935B2 (en) 2014-03-18
JP5296678B2 (ja) 2013-09-25
CA2658400C (fr) 2015-02-10
CA2658400A1 (fr) 2008-01-24
JP2009543854A (ja) 2009-12-10
ATE454889T1 (de) 2010-01-15
FR2903905B1 (fr) 2009-03-06
ES2335623T3 (es) 2010-03-30

Similar Documents

Publication Publication Date Title
GEP20146060B (en) Pyridyl inhibitors of hedgehog signalling
IN2012DN02805A (de)
MA32200B1 (fr) Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
MX2011012122A (es) Derivados de tiofeno.
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
MY148534A (en) Inhibitors of human immunodeficiency virus replication
EA200900343A1 (ru) Устойчивые оральные фармацевтические дозированные формы, содержащие опиоидный анальгетик
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
UA110199C2 (xx) Тверда дисперсія рифаксиміну
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
WO2009130422A3 (fr) N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
DE602007004348D1 (de) Arzneimittel zur behandlung von sarkoglykanopathien
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
MX2008011020A (es) Compuestos de receptor sigma.
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
AU2010323104A8 (en) Sialochimeric compounds
IL191670A0 (en) Compounds for the inhibition of apoptosis
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.
UA93190C2 (ru) Соединения нафталина, способ их получения и фармацевтическая композиция, которая их содержит
UA93864C2 (ru) Соединения нафталина, способ их получения и фармацевтическая композиция, которая содержит их
DE602005011029D1 (de) Therapeutisches mittel zur behandlung von plasmazellneoplasien
MX2008011017A (es) Compuestos de receptor sigma.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition